Product Overview - Dr Falk

Sign in

Some information on this website may be viewed only by healthcare professionals.
If you would like to enter this section then please register as a healthcare professional.
Dr Falk Pharma UK Ltd Privacy Policy can be found here.


Register

Please note that our privacy policy has recently been updated. Click here to review the policy.

Register

Please fill out your details below to register for our site for healthcare professionals.

Please specify your preferred contact email address
Please specify your password, which should be a minimum of 8 characters, including at least one number and one capital letter
Passwords do not match
Please specify your salutation
Please specify your name
Please specify your last name
Please specify your position
Please specify your interest
Please specify your institution
Please enter a post code
Post Code not found
Please specify your practice name
Please specify your practice address
Please specify your practice town
Please specify your practice post code
Please specify a valid mobile number
Please specify a valid number

Please confirm you are a UK/Ireland HCP

Please review the Dr Falk Pharma UK Ltd Privacy Policy before registering.

We assure you that we work hard to keep your personal data secure and will not share any details with a 3rd party without your explicit consent.

You will be given the opportunity to unsubscribe during every communication.

You can update your preference at any time by contacting privacy@drfalkpharma.co.uk.

Products

Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding and treatment of digestive and metabolic diseases. View our comprehensive product range below.

The following pages contain comprehensive information on the Dr Falk Pharma product range. We produce four different therapies designed to treat inflammatory bowel conditions, Eosinophilic Oesophagitis and Cholestatic Liver Disease.

This information on the following pages is intended only for UK and Irish residents who have been prescribed either Budenofalk, Salofalk, Ursofalk or Jorveza.